Trial Profile
A prospective randomized trial to investigate whether administration of a loading dose of rosuvastatin before percutaneous coronary intervention has better myocardial protective effects than administration of conventional dose
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- 01 Dec 2015 New trial record